Jpmorgan Chase & CO Atrion Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATRI
# of Institutions
109Shares Held
1.12MCall Options Held
0Put Options Held
0-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA205KShares$00.23% of portfolio
-
Black Rock Inc. New York, NY108KShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA87.8KShares$00.0% of portfolio
-
Morgan Stanley New York, NY62KShares$00.0% of portfolio
-
Glazer Capital, LLC New York, NY53.9KShares$01.89% of portfolio
About ATRION CORP
- Ticker ATRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 1,785,990
- Description
- Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...